Tag Archives: Elisabeth Bik
Numbed by numbers
Couple things in my news feed this morning that really woke me up — one a startling statistic and the other a reminder of what statistics miss. The first from Nature, ‘How to win a Nobel prize: what kind of … Continue reading
NCBS fracas: In defence of celebrating retractions
Continuing from here… Irrespective of Arati Ramesh’s words and actions, I find every retraction worth celebrating because how hard-won retractions in general have been, in India and abroad. I don’t know how often papers coauthored by Indian scientists are retracted … Continue reading
NCBS retraction – addenda
My take on the NCBS paper being retracted, and the polarised conversation that has erupted around the incident, is here. The following are some points I’d like to add. a. Why didn’t the editorial and peer-review teams at Nature Chemical … Continue reading
The costs of correction
I was slightly disappointed to read a report in the New York Times this morning. Entitled ‘Two Huge COVID-19 Studies Are Retracted After Scientists Sound Alarms’, it discussed the implications of two large studies of COVID-19 recently being retracted by … Continue reading
Distracting from the peer-review problem
From an article entitled ‘The risks of swiftly spreading coronavirus research‘ published by Reuters: A Reuters analysis found that at least 153 studies – including epidemiological papers, genetic analyses and clinical reports – examining every aspect of the disease, now called … Continue reading
To see faces where there are none
This week in “neither university press offices nor prestigious journals know what they’re doing”: a professor emeritus at Ohio University who claimed he had evidence of life on Mars, and whose institution’s media office crafted a press release without thinking … Continue reading